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Background: Suicide attempts (SA) and other types of self-harm (SH) are strong
predictors of death by suicide in adolescents, emphasizing the need to investigate
therapeutic interventions in reduction of these and other symptoms. We conducted an
updated systematic review of randomized controlled trials (RCTs) from our previous study
reporting therapeutic interventions that were effective in reducing SH including SA, while
additionally exploring reduction of suicidal ideation (SI) and depressive symptoms (DS).
Method: A systematic literature search was conducted across OVIDMedline, psycINFO,
PubMed, EMBASE, and Cochrane Library from the first available article to October
22nd, 2017, with a primary focus on RCTs evaluating therapeutic interventions in the
reduction of self-harm. Search terms included self-injurious behavior; self-mutilation;
suicide, attempted; suicide; drug overdose.
Results: Our search identified 1,348 articles, of which 743 eligible for review, yielding
a total of 21 studies which met predetermined inclusion criteria. Eighteen unique
therapeutic interventions were identified among all studies, stratified by individual-driven,
socially driven, and mixed interventions, of which 5 studies found a significant effect for
primary outcomes of self-harm and suicide attempts (31.3%), and 5 studies found a
significant effect for secondary outcomes of suicidal ideation and depressive symptoms
(29.4%) for therapeutic intervention vs. treatment as usual. Collapsing across different
variations of Cognitive Behavior Therapy (CBT), and classifying Dialectical Behavior
Therapy for Adolescents (DBT-A) as a type of CBT, CBT is the only intervention with
replicated positive impact on reducing self-harm in adolescents.
Conclusion: While the majority of studies were not able to determine efficacy of
therapeutic interventions for both primary and secondary outcomes, our systematic
review suggests that individual self-driven and socially-driven processes appeared to
show the greatest promise for reducing suicide attempts, with benefits of combined
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self-driven and systems-driven approaches for reducing overall self-harm. Further
RCTs of all intervention categories are needed to address the clinical and etiological
heterogeneity of suicidal behavior in adolescents, specifically suicidal ideation and
depressive symptoms.
Keywords: suicide, self-harm, NSSI, depression, suicidal ideation, adolescent, RCT
INTRODUCTION
Suicide is a major global and public health concern (1). It is
the second leading cause of death in people age 15–24 years (2)
and there is a pressing need to identify effective interventions
to reduce the risk of suicide. Non-fatal suicide attempts (SA)
can be defined as self-directed injuries with implicit or explicit
intent to kill oneself, while non-suicidal self-injury (NSSI) is
direct destruction of one’s body without intention to die (3).
For the latter, it is useful to consider the definition of non-
suicidal self-injury found in the DMS-5, which states that the
preoccupied individual partakes in premeditated, self-directed
damage to themselves in order to relieve negative experiences and
does not exhibit suicidal intent through this behavior (4). Both
suicide attempts (SA) and the broader category of “self-harm”
(SH, which includes non-suicidal self-injury) are among the
strongest predictors of death by suicide (5–7), and have therefore
appropriately been the focus of therapeutic interventions for
adolescents to decrease risk of suicide.
There has been significant progress in detection (8),
identifying subtypes, understanding the long-term outcomes (9),
and understanding help-seeking in adolescents with SH (10).
There has also been recent progress regarding the treatment
of self-harm in adolescents. We conducted the first meta-
analysis of randomized controlled trials (RCTs) to specifically
evaluate therapeutic interventions (TIs) in reducing SH in
adolescents (11). A significant effect was found for tested
interventions reducing SH compared to treatment as usual
(TAU). While results evaluating the effects of therapeutic
interventions on NSSI were generally consistent with those
for overall self-harm, the effect size was weaker and escaped
statistical significance. In contrast, there was little to no evidence
of benefits of tested interventions in reducing suicide attempts.
Our findings highlighted both the beneficial effects of therapeutic
interventions for self-harm as a global category, the challenges
of reducing the risk of future suicide attempts and the need for
rigorous and replicable studies.
In addition to self-harm and suicide attempts, however,
depression in adolescence is another key contributor to suicidal
behavior (12, 13). A recent National Confidential Inquiry into
Suicide and Homicide by People with Mental Illness (NCISH)
report of suicide deaths in England and Wales between 2014 and
2015 indicated that out of 285 suicide deaths that occurred in
youths aged 10–20, 52% had a history of SH, while 58% expressed
thoughts of suicide or hopelessness (14). Depressive symptoms
themselves have been found to be significant and independent
contributors to elevated levels of deliberate self-harm in young
people (15–18). Therefore, it would appear that the reduction
of depressive symptoms and suicidal ideation (19) may be an
important mechanism underpinning the effectiveness of certain
treatments for suicide prevention.
We therefore sought to extend and update our initial meta-
analysis focused on the reduction of self-harm and suicide
attempts, while also examining the effect of a variety of unique
therapeutic interventions on levels of depressive symptoms and
suicidal thoughts. In this way, we acknowledge the relevance
of these mechanisms to the field and aim to advance our
previous study findings with a wider criterion and selection
of interventions. Our primary outcomes were the reduction in
self-harm including NSSI or suicide attempts (SAs), and our
secondary outcomes were the reduction in suicidal ideation (SI),
meaning thoughts and feelings related to suicide, as well as
depressive symptoms (DS).
METHODS
Eligibility and Selection
We followed the same methodology as our previous systematic
review [see (11)], using “self-harm” as an encompassing term,
including previous suicide attempts, non-suicidal self-injury,
and deliberate self-harm with undetermined intent. However,
in addition to the original systematic review’s reduction of
self-harm and suicide attempts (primary outcomes) we also
examined decrease of suicidal ideation and depressive symptoms
(secondary outcomes) as markers of the efficacy of the
therapeutic interventions.
Inclusion Criteria
Inclusion to the update depended on: study type, sample age, and
frequency of self-harm occurring within the sample.We included
only studies which were clinical, randomized trials of therapeutic
interventions, defined as any theoretically coherent, manualized,
psychological, psychosocial, or pharmacological intervention,
compared to a placebo or control treatment (11). Further,
we included only studies with a majority (>50%) child and
adolescent population (<18 years old), engaged in either self-
harm or had attempted suicide. Studies from all countries and
languages were considered eligible, if they were accompanied by
an English abstract.
Exclusion Criteria
Potential studies were excluded from the update if self-harm
was a symptom of an overarching developmental condition (i.e.,
autism or intellectual disability). Finally, studies that did not
meet the threshold score of >2 on the Jadad quality assessment
tool (20), specifically used to ascertain methodological quality,
coherence to blinding and allocation procedures, and amenability
to participant attrition, were excluded from consideration.
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Literature Search Strategy
A literature search was conducted through standard online
databases (OVID Medline, psycINFO, PubMed, EMBASE, and
Cochrane Library) in order to identify RCTs evaluating the
efficacy of therapeutic interventions for adolescents with self-
harm against control conditions. To maintain consistency with
our first study, the same inclusion and exclusion criteria
were utilized in this update. We excluded studies in which
self-harm occurred as a result of stereotypic self-injurious
behaviors such as those seen in moderate to severe forms
of neurological disorders (e.g., Autism, Intellectual Disability),
due to the complex neurological mechanisms which underlie
the self-harm not otherwise seen outside of these conditions.
All the aforementioned databases were searched from the first
available article until October 22nd, 2017. Consistent with our
original methodology, the following subject headings or MeSH
keywords were used: self-injurious behavior; self-mutilation;
suicide, attempted; suicide; drug overdose. When available, filters
for study type and participant age were applied, with an
additional manualized filter used for psycINFO to specifically
identify clinical trials.
RESULTS
Study Selection
A total of 1,348 articles were found, with 743 of those studies
eligible for review following duplicate removal (Figure 1). The
screening procedure consisted of three phases: title, abstract and
full text screening, with the latter two conducted independently
by the two authors (UI andNS). Title screening was conducted by
NS as a preliminary measure to ensure the exclusion of any not-
pertinent studies and duplicates, reducing the number of eligible
studies from 743 to 102. Within the abstract screening phase, 31
articles were eliminated as they failed to meet any one aspect of
the inclusion criteria, producing a yield of 71 articles for full text
screening. In the third and final phase, we excluded 50 studies,
16 of which had a sample with a mean age above 18 years, 23
which did not have a majority of adolescents who engaged in
self-harming behaviors, 9 which were not RCTs, 1 which has been
replaced by a paper with more recent follow-up data, and 1 which
did not meet quality standards. We chose to remove one study
included in the original systematic review (21), as its investigation
of a treatment designed to increase linkage to outpatient services
did not assess the same outcomes which we are addressing in this
update. Disagreements in any phase of the screening process were
resolved by consensus discussion between the authors (UI and
NS).
Therapeutic Interventions
The final selection of 21 studies contained 18 unique therapeutic
interventions. Two of the final 21 studies (22, 23) were
replication trials assessing the efficacy of Developmental Group
Psychotherapy (24), while another paper (25) was a follow-up
to a previous pilot trial of Emotion Training Regulation (ERT)
(26). As such, 18 unique interventions were identified among all
studies. To facilitate analysis, the interventions can be stratified
and evaluated by the underlying theoretical principles, including
self-driven cognitive, behavioral and regulatory interventions
(referred to as self-driven) and interventions which require
engagement with family and social support (referred to as
socially-driven). A brief description of the interventions and
the study origins are listed in Table 1, with self-driven and
socially-driven components identified for each respective study
inTable 2. Results below are reported first by interventions which
we believed had a primarily self-driven focus, followed by those
with a primarily socially-driven focus, and finally, interventions
which demonstrated aspects of both self-driven and socially-
driven principles.
Primary Outcome Assessment
Table 3 provides a brief summary of primary outcomes of the
studies for comparison of therapeutic intervention examined,
and those that had significant group differences, significant
overall differences, or null or negative findings. Of the 21 studies
examined, 16 studies explored primary outcomes, out which
5 (31.3%) found significant group differences for intervention
vs. treatment as usual (24, 28, 31, 32, 42), across all types of
treatments.
Significant Differences in Therapeutic Interventions
vs. Treatment as Usual
We first examined interventions that addressed individual
problem solving, mentalization, cognitive behavior or skills
deficits [these included treatments such as Cognitive Behavioral
Therapy [CBT], Mentalization Based Therapy [MBT], Dialectical
Behavioral Therapy [DBT]]. The only identified studies with a
purely self-driven intervention model were those that evaluated
Developmental Group Psychotherapy, an intervention which
used cognitive-behavioral, problem-solving, dialectical, and
psychodynamic group psychotherapy strategies. In a small initial
trial among adolescents with repeated SH referred to child and
adolescent mental health services in the UK, Developmental
Group Psychotherapy compared to treatment as usual was
associated with a significantly lower risk of repeating self-harm,
with a lower latency period for repeated attempts, indicating
an absolute risk reduction of 26% (24). The authors cautioned
that this strong effect was likely due to a smaller sample, and
urged replication studies with a larger sample. Indeed, two
efforts at replication failed to find a significant advantage for the
Developmental Group Psychotherapy intervention. These trials
included one conducted in Australia with supervision from the
original UK development team and somewhat different sampling
criteria: youths referred for general child and adolescent mental
health services identified with repeat self-harm (22). The other
trial was a large trial (N = 366) conducted in the UK with
members of the original development team and also failed to find
an advantage for the Developmental Group Psychotherapy (23)
over treatment as usual.
One study conducted in Australian outpatient mental health
clinics used a socially driven intervention to evaluate a strength-
based family education program, called Resourceful Adolescent
Parent Program (RAP-P). Among patients recruited suicidal
adolescents from emergency departments or public mental
health services, the RAP-P program resulted in a significant
improvement on a 9-item suicide index assessing suicide
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FIGURE 1 | Study flow diagram.
ideations, plans, threats, self-harm, and suicide attempts both
at the 3-month post-treatment point, and at a 6-month follow-
up compared to treatment as usual (41). This study was the
only exclusively socially-driven intervention model to find a
significant group difference on primary outcomes and it should
be noted that the outcome variable was a broad measure of
suicidality rather than a measure specifically of self-harm or
suicide attempts.
Four trials examined more combined self-driven and
system driven approaches. We begin with Mentalization-Based
Treatment for adolescents (MBT-A), a manualized one-year
psychodynamic psychotherapy rooted in attachment theory.
MBT-A has a strong self-driven component consisting of
weekly individual MBT-A sessions and compared to the other
approaches in the combined approach group, the weakest of
the socially-driven components; specifically, monthly family
Mentalization-based family therapy. In an initial trial, Rossouw
and Fonagy (32) found that adolescents selected for the presence
of both self-harming behaviors and depression in the MBT- A
condition had fewer self-harm episodes over the course of the
treatment compared to treatment as usual youths and that the
MBT-A group had a higher recovery rate and a reduction of self-
harm at the end of the 12-month treatment. Thus, results from
this initial trial support the efficacy ofMBT-A for reducing overall
self-harm. Results specifically for suicidal behavior were not
reported.
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TABLE 1 | Descriptions and Study Origins of Therapeutic Interventions of the Selected Randomized Controlled Trials.
TI name Study origin Description
CBT-SP Alavi et al. (27) A 3-phase Cognitive-Behavioral Therapy protocol adapted specifically for suicide prevention. Utilizes cognitive
behavioral principles according to the Stanley et al. model, and is comprised of 12 weekly sessions, the first of
which includes parents.
Integrated Cognitive
Behavioral Therapy
(I-CBT)
Esposito-Smythers
et al. (28)
Utilizes cognitive behavioral techniques such as restructuring, problem-solving, affect regulation and
communication skills to remediate maladaptive cognitions and provide skills training for the attending adolescent
and parents. One-year long intervention consisting of three treatment phases, involving with weekly, bi-weekly,
and monthly individual adolescent, family, and parent training sessions.
DBT-A Mehlum et al. (29) Streamlined Dialectical Behavioral Therapy protocol adapted for adolescents, incorporating a new skills module to
address emotion dysregulation amongst adolescents and their families. Nineteen-week long intervention involving
weekly individual therapy, multi-family skills training, and family therapy sessions.
Developmental Group
Psychotherapy
Wood et al. (24) Integrates techniques from problem solving and cognitive and dialectical behavioral interventions to resolve issues
around relationships, school problems, peer relationships, depression and self-harm, hopelessness, and feelings
about the future. Delivered through a maximum of 19 acute and long-term group sessions run in tandem,
administered by a variety of trained personnel.
Skills-Based Treatment
(SBT)
Donaldson et al. (30) Intervention designed to target problem solving and affect management skills in self-harming adolescents through
cognitive behavioral strategies such as restructuring and relaxation. Delivered by therapists trained in SBT for an
undefined number of sessions (mean number of sessions: 9.25).
Emotion Regulation
Training (ERT)
Donaldson et al. (26) Designed to teach participants ways of coping with affective instability, daily stressors, and psychological
vulnerability through psychoeducation and behavior modification. Treatment is conducted through 17 weekly
multi-phase group sessions delivered by therapists trained in ERT.
Safe Alternative for
Teens and Youth
(SAFETY)
Asarnow et al. (31) Emergency Department (ED) family-centered intervention informed by CBT and DBT aimed to reduce future
suicide attempts by strengthening protective supports, teaching skills for managing stress reactions and
formulating strategies for creating a safe environment for the adolescent. Treatment is conducted through 12
weekly individual and joint sessions for adolescents and their parents, delivered by two therapists, each working
with the family.
Mentalization Based
Therapy for
Adolescents (MBT-A)
Rossouw and Fonagy
(32)
An adapted form of Mentalization-based Treatment, a manualised intervention focusing on impulsivity and affect
regulation, helping to enhance the patient’s understanding of how to represent feelings in emotionally challenging
situations. Year-long intervention with weekly individual and family based therapy (MBT-F) delivered by trained
therapists.
Cognitive Analytic
Therapy (CAT)
Chanen et al. (33) Time limited, integrated model of development and psychopathology, equipping the patient with tools more
effectively manage stressful situations which could lead to a repetition of pathological behavior. Conducted
through 24 weekly sessions delivered by therapists trained in CAT.
Therapeutic
Assessment
Ougrin et al. (34) Manualised assessment protocol for self-harming adolescents facilitating the identification of the target problem,
enhancing motivation for change, and exploring ways of relieving vicious cycles. Assessment takes place in one
session and is delivered by a trained clinician.
Emergency Tokens Cotgrove et al. (35) Self-harming adolescents were allotted a token allowing hospital re-entry without question, to be used when
adolescent was in need of escaping an intolerable (family) environment.
Home-based Family
Intervention
Harrington et al. (36) Short-term, intensive, focused, action orientated intervention used to address family dysfunction without lengthy
treatment commitments or the need to present to a hospital setting. Conducted by psychiatric social workers
during 5 home-based therapy sessions.
Family Intervention for
Suicide Prevention
(FISP)
Asarnow et al. (6) Brief ED intervention which focuses on building a collaboration between adolescents and their parents by
identifying and addressing the causes, reaction, and future actions related to the committed suicide attempt.
Administered by a trained clinician.
Family-Based Crisis
Intervention
Wharff et al. (37) Brief intervention which provides the family with tools to manage current and future crises through
psycho-education, cognitive behavioral skill building, therapeutic readiness and safety planning. Delivered during
the adolescent’s visit to the ED by a research clinician.
Attachment-Based
Family Therapy (ABFT)
Diamond et al. (38) Designed to improve problem solving, affect regulation and organization within the family. Number of sessions
vary, depending on the adolescent’s progress in resolving 5 specific tasks, and is delivered by a therapist trained in
ABFT.
Youth Nominated
Support Team-I
King et al. (39) Supplements routine care by facilitating weekly contact between adolescents and their chosen support person
(outside of the family), based on the notion that support people may minimize the impact of negative family
environment. Support is provided to their adolescent by their nominated individual, who is asked to be in weekly
contact with the adolescent. Support personnel are given 1.5–2 h of training.
Youth Nominated
Support Team-II
King et al. (40) Similar to YST-I, but with updated psychoeducation materials and the requirement that the nominated support
person be an adult (rather than a peer). The support person has weekly check-ins with the adolescents for 3
months following hospitalization.
Resourceful Adolescent
Parent Program
(RAP-P)
Pineda and Dadds (41) Strengths-based family psycho-education program, enhancing understanding of SH and SA, along with strategies
to help minimize future self-injurious behavior, and information to facilitate access to support services. Sessions
2 h and held once a week or fortnightly.
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Dialectical Behavioral Therapy for Adolescents, (DBT-A)
addresses self-driven cognitive-behavioral and regulatory
processes (e.g., emotion regulation, distress tolerance, and
interpersonal effectiveness) and the social environment through
inclusion of a weekly multi-family skills training group and as
needed family therapy sessions. A first RCT evaluating DBT-A
was conducted in Norwegian clinics and recruited youths
with both at least two episodes of self-harm and symptoms
of borderline personality disorder (43). This trial compared
DBT-A to treatment as usual enhanced by a therapist agreement
to provide at least 1 weekly session during the trial. Results
indicated that the 19-weeks DBT-A reduced the frequency of
self-harm with large effect sizes, compared to moderate and weak
effect sizes in the TAU condition (29). The advantage of DBT-A
for reducing self-harm extended to a 1-year post-treatment
follow-up, with DBT-A youths continuing to demonstrate
fewer episodes of self-harm compared to treatment as usual
youths (42). The authors looked at a range of additional clinical
outcomes including suicidal ideation, hopelessness, depression,
borderline symptoms, and global functioning. Results indicated
that while there was an initial advantage for DBT-A and DBT-A
youths continued to show improved clinical and functioning
outcomes at the 1-year post-treatment follow-up, with time the
TAU youths caught up and looked similar to the DBT-A youths
on these more general outcomes. This trial was not powered to
evaluate outcomes regarding suicide attempts, thus such data
were not reported.
The combined self-driven and socially-driven intervention
model was used in two U.S. treatment development trials. Both
trials used a 2-therapist model with one therapist focusing on
the youth and the other the parent, and both studies showed
evidence of benefits in reducing the risk of suicide attempts.
First, Esposito-Smythers et al. (28) tested an integrated CBT (I-
CBT) protocol for suicidality (along with co-occurring alcohol
and drug related problems) and found that those randomized to
I-CBT had fewer suicide attempts over the course of 18-months
compared to those in the control condition. Second, Asarnow
et al. (31) developed a DBT-informed cognitive-behavioral family
treatment (referred to as SAFETY) which included attention to
strengthening self-driven cognitive, behavioral and regulatory
processes in the youth and parents, and family sessions aimed
at promoting increased support and protection within the
family and broader social environment. Results of this trial
indicated a statistically significant advantage for SAFETY in
decreasing suicide attempts over the 3-month treatment period,
and reducing the risk of a first incident suicide attempt over
a 6 to 12-month follow-up period. Weaker non-significant
group differences were found for non-suicidal self-injury. While
results of these trials are encouraging, it should be noted
that both studies were relatively small treatment development
trials, underscoring the need for cautious interpretation until
replication is achieved.
Overall Group Differences Irrespective of Therapeutic
Intervention
Overall symptom reduction across both treatment and control
groups was found throughout several other studies included
in this review, not specific to intervention type, including the
Green et al. (23) trial of Developmental Group Psychotherapy
intervention. In a specific clinical sample of Borderline
Personality Disorder (BPD), three studies assessed the efficacy
of cognitively-informed interventions. Chanen et al. (33) and
Schuppert et al. (25, 26) investigated the efficacy of Cognitive
Analytic Therapy (CAT) and Emotion Regulation Training
(ERT), respectively, against TAU. Both CAT and ERT emphasize
ways to react and respond to stressful situations with tools to
more effectively manage stressful situations with aspects of self-
driven processes. Both studies only observed the reduction of
self-harm within the whole cohort with no statistically significant
group differences, indicating that these therapies do not appear
to perform any better than TAU in reducing self-harm within
Borderline patients.
Null or Negative Findings
Several interventions included in this update demonstrated
non-significant or negative findings. For instance, The Youth-
Nominated Support Treatment (YST-I) is a socially driven
treatment that focuses on improving support in youths’ social
support network and is added to TAU, with version II of the
intervention focused on strengthening social support in youth-
nominated supportive adults, rather than adults and peers. In
both YST-I (39) and YST-II (40), no significant treatment effect
was found in reduction of SA; authors emphasized the need for
further research using this mode.
Cotgrove et al. (35) demonstrated non-significant findings
regarding secondary prevention of suicide attempts in
adolescents, examining re-admissions to Emergency Rooms.
Adolescents were randomly allocated to a group receiving tokens
guaranteeing re-admission to emergency services if they felt
unable to cope within their environment. While there was no
significant difference noted between adolescents with tokens and
those without, those in the treatment condition had fewer repeat
attempts than the control group, suggesting possible efficacy of a
secondary prevention mechanism.
Two studies identified advantages of brief mental health
interventions for linking youths to outpatient treatment
after emergency presentation for suicidality and/or self-harm.
Asarnow et al. (6) looked at a brief, cognitive-behavioral family-
based Emergency Department (ED) intervention and found an
advantage of the this intervention compared to treatment as usual
for establishing linkage to outpatient care (the primary study
outcome). Clinical outcomes were not evaluated close in time to
the Emergency Department intervention. However, when clinical
outcomes were evaluated roughly 2 months after discharge from
the Emergency Department, no statistically significant advantage
was found for this intervention in reducing suicide attempts.
Importantly, there was also no evidence that linkage to outpatient
treatment as usual after discharge from emergency services
had any advantages relative to no post-discharge community
treatment as usual.
Ougrin et al. (34) applied a brief therapeutic intervention
incorporating elements of cognitive analytic therapy called
Therapeutic Assessment (TA) following emergency presentation
of self-harm. While there was no significant difference in the
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TABLE 2 | Types of Therapeutic Intervention for the Selected Randomized Controlled Trials and Aspects of Individual or Social Components.
Self-driven Components Social Components
CBT DBT MBT CAT Problem
Solving
Social
Support
Family
Involvement
Psycho-
education
Communication
skills
Alavi et al. (27) •
Asarnow et al. (6) •
Asarnow et al. (31) • • •
Cotgrove et al. (35)
Chanen et al. (33) •
Diamond et al. (38) •
Diamond et al. (30) • • •
Esposito-Smythers et al. (28) • • •
Green et al. (23) • • • •
Harrington et al. (36) •
Hazell et al. (22) • • • •
King et al. (39) • •
King et al. (40) • •
Mehlum et al. (42) • • •
Ougrin et al. (34) • •
Pineda and Dadds (41) • •
Rossouw et al. (32) • •
Schuppert et al. (26) •
Schuppert et al. (25) •
Wharff et al. (37) • •
Wood et al. (24) • • • •
frequency of self-harm resulting in emergency presentations
between the Therapeutic Assessment and treatment as usual
groups, overall treatment engagement remained higher in
the Therapeutic Assessment group than the control group.
Collectively, the Asarnow et al. & Ougrin et al. studies
underscore the value of brief mental health interventions for
improving linkage to outpatient treatment after emergency
presentation for self-harm and suicidality, as well as
the importance of efforts to identify effective treatment
strategies and implement them effectively within community
programs.
Secondary Outcome Assessment: Suicidal
Ideation, Depression, Other Clinical, and
Functioning Outcomes
Significant Differences in Therapeutic Interventions
vs. Treatment as Usual
Of the possible 21 studies, 17 studies explored secondary
outcomes of depressive symptoms and suicidal ideation, of which
5 (29.4%) yielded significant differences by the intervention.
Beginning with studies using primarily self-driven interventions,
MBT-A was found to yield a significant reduction in depressive
symptoms at the 12-month point (32). Both the treatment
and control group showed reduced depressive symptoms, and
a significant reduction over time was seen only in MBT-A
youths condition. The largest mean difference between groups
was seen at 9 months. Using a 12-week treatment period,
Alavi et al. (27) evaluated the CBT-Suicide Prevention (CBT-SP)
treatment developed for the Treatment of Adolescent Suicide
Attempter’s (TASA) study (44), results indicated significant
reductions in both suicidal ideation and depressive symptoms
at the end of the 3-month treatment period. These results are
similar to those from the TASA trial, which was originally
designed as an RCT but random assignment was discontinued
due to patients’ reluctance to accept randomization. The
TASA trial found relatively low rates of suicidal events,
including suicide attempts, interrupted suicide attempts, and
levels of suicidal ideation requiring emergency evaluation or
hospitalization (19) as well as declines in suicidal ideation
and depressive symptoms over the 6-month treatment period
(45).
For interventions focusing on social support and
psychoeducation strategies, King’s investigations of both
versions of the Youth-Nominated Support Team intervention
decreased suicidal ideation over time in both groups. Further,
the first version of the intervention, YST-I, allowed both
youth-nominated peers and adults in the Support Team and
demonstrated a small to medium effect on the reduction of
suicidal ideation only after altering analyses from intent-to-
treat to actually treated; an effect that was seen only in female
participants (39). Following with a study of the adapted YST-II
intervention, which focused on youth-nominated adults, King
again demonstrated a small to medium effect in the reduction of
suicidal ideation, this time, only in those participants who had a
history of multiple suicide attempts (40).
Another socially-driven intervention, Attachment-Based
Family Therapy (ABFT), compared to TAU, was shown to
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have very strong effects in reducing suicidal ideation during
all points of treatment with the strongest effect observed at 24
weeks, the final follow-up (38). This effect was seen within the
total sample, and within a subsample of adolescents who met
the diagnostic criteria for clinical depression. Additionally, a
significant effect in the reduction of suicidal ideation was seen
within the Home-Based Family intervention, but only when
controlling for depression.
Overall Group Differences Irrespective of Therapeutic
Intervention
Reductions over time in suicidal ideation were observed in nearly
all studies, including those evaluating mentalization treatment,
DBT-A, integrated CBT for suicidality and substance abuse,
skills based treatment, youth-nominated support teams, and
attachment based family treatment (28–30, 32, 38).
While a significant reduction in ideation was observed in
3 studies based on social or family models (38–40), none of
these studies identified significant differences in the reduction
of depressive symptoms between treatment and control groups
at the final follow-up measure. The Attachment-Based Family
therapy intervention appeared close to producing a nearly
significant result at the 6 and 12-week measurements, but was
unable to reach statistical significance altogether at the end of the
trial (38).
When examining socially-driven interventions within an
emergency service settings, Asarnow et al. (6) did not examine
suicidal ideation or depressive symptoms close in time to the
emergency intervention. However, when followed up roughly 2-
months post -hospital discharge there were significant declines
in depressive symptoms across groups. Of the socially-driven
interventions administered during a presentation to emergency
services or at the time of a psychiatric assessment, only Wharff
investigated whether a Family-Based Crisis Intervention, a multi-
module single session intervention would impact the adolescent’s
suicidal ideation (46). While an overall reduction in suicidal
ideation was seen within the cohort, there was no significant
treatment effect. In contrast to the other studies included this
review,Wharff conducted pre-and post-test measures a mere 4–h
apart.
Null or Negative Findings
Despite noting significant group differences in primary
outcomes, Wood et al. (24) found no significant effect of
Developmental Group Psychotherapy on reducing depressive
symptoms and suicidal ideation. Consistent with what was
noted for primary outcomes, neither of the two additional trials
evaluating the same treatment (22, 23) saw treatment effects in
secondary outcomes of reducing suicidal ideation or depressive
symptoms.
Asarnow et al. (6) found no statistically significant advantage
of the Emergency intervention in reducing depression levels,
even though the intervention was associated with improved
linkage to outpatient mental health services was observed.
Indeed, there was no evidence that attendance in outpatient
community treatment as usual was associated with lower
depressive symptoms or suicidality.
DISCUSSION
We set out to examine the available literature for adolescents
with a recent history of self-harm or suicide attempt,
with the overall aim of clarifying which therapeutic
interventions and approaches show evidence of benefits
for reducing self-harm, suicide attempts, as well as suicidal
ideation and depressive symptoms. Of the 18 unique
interventions identified through this review, treatments
that target individual, self-driven (cognitive-behavioral, self-
regulatory processes) and socially-driven (family or social
support network) processes appeared to show the greatest
promise for reducing suicide attempts (28, 31), and there
are data supporting the benefits of DBT-A and MBT-A
(combined self-driven and systems-driven approaches),
for reducing overall self-harm. If the somewhat different
variations of CBT are considered together, and DBT-A is
classified as a type of CBT, CBT is the only intervention
type where initial positive findings have been replicated
independently. It should be noted, however, that all of the
CBT interventions with evidence for efficacy have strong
family systems-driven components (I-CBT, SAFETY, DBT-
A). Other interventions with initial positive outcomes, such
as MBT-A require testing in adequately powered trials and
replication.
The results of this review update are demonstrative of
the effectiveness of DBT-A and CBT, the only interventions
where initial positive findings have been replicated
independently. These interventions are therefore an
invaluable part of the clinical treatment of young people
who present with self-harm and a history of suicide
attempts.
Turning to the secondary outcomes of suicidal ideation and
general measures of suicide risk, current research supports
the efficacy of attachment based family treatment and the
Resourceful Adolescent Parent Program. Results were not
reported on suicide attempts specifically or self-harm in either
trial, and replication is needed. While not all studies have
reported on suicidal ideation when suicide attempts and
self-harm were primary outcomes, both MBT-A and DBT-
A have shown significant advantages in reducing both self-
harm and suicidal ideation. Rossouw and Fonagy (32) reported
an advantage for MBT-A compared to treatment as usual at
end of the year-long treatment. Mehlum et al. (42) similarly
reported an advantage for DBT relative to treatment as usual at
end of treatment, which was at 16 weeks, although treatment
as usual youths had caught up with the DBT-A youths by
71-weeks.
Results on depression outcomes tended to be similar to
those for suicidal ideation, with a tendency for depression
levels to diminish over time, and between group differences
observed in the studies and time points where benefits on suicidal
ideationwere observed. The two studies that evaluated borderline
symptoms (DBT-A and MBT-A) reported intervention benefits
in reducing symptoms of Borderline Personality Disorder. Both
suicidal ideation and depressive symptoms have been shown
to precipitate non-suicidal self-injury and suicide attempts
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in adolescents (19, 47), and thus should not be overlooked
as integral symptoms to address during treatment in future
research.
Overall, the studies which showed significant effects in
the reduction of outcomes at any point during treatment
(without adjustments) were similar in several characteristics.
First, these interventions mandated the family or support
person’s involvement in the adolescent’s therapeutic journey
in addition to the adolescent’s individual therapy; five
interventions included parental involvement throughout
the duration of the intervention, through family training,
family therapy, and/or family planning (28, 29, 31, 32, 38, 41).
The Responsible Adolescent Parenting Program (2013) was
the only exclusively socially-driven parenting intervention
that yielded significant effects, suggesting a need for
replication studies using this treatment. Finally, we noted
that the effective interventions all share emotion regulation,
problem solving, and communication skills as key tenets
of the intervention. While dysregulated affect is shown to
be a predictor of suicide attempts and non-suicidal self-
injury (47), subsequent research is needed to assess whether
problem-solving and communication skills would contribute
to the reduction of self-harm, suicidal ideation, or depressive
symptoms.
The current National Institute for Health and Care Excellence
(NICE) guidelines (48) for the treatment of adolescents with
self-harm, suggest tailored treatments incorporating elements
of cognitive behavioral, psychodynamic and problem-solving
therapies. Results of this review are generally consistent with
these guidelines, and clinical guidance is needed to support
optimal clinical care for this potentially life-threatening problem.
However, it is important to note that the evidence is limited.
We still lack replicated evidence of treatment efficacy for any
of the reviewed interventions. It is also important to note that
the sampling protocols and populations differed across studies,
and these sampling differences could lead to differences in
treatment efficacy and study results. For instance, the DBT-A
trial selected youths based on the presence of repeated self-harm
and symptoms of borderline personality disorder, the MBT-A
trial selected youths for the presence of self-harm within the
past month, the Integrated CBT model recruited youths with
both suicidality (attempts or ideation) and substance abuse,
the SAFETY trial selected youths based on the presence of
suicide attempts or repeated self-harm, and the Peer Nominated
Support Team trials recruited youths with previous suicide
attempts or suicidal ideation. Because trials were conducted
across different nations and health systems, “treatment as usual”
will have varied considerably, and this could conceivably have
affected the observed between group differences. Further, with
few exceptions (32, 41) studies have not yet reported on treatment
mediators and studies aimed at treatment mechanisms associated
with reduced fatal and non-fatal self-harm risk would help
guide the field. Research focusing on targeted interventions such
as those aimed at reducing access to dangerous methods of
self-harm (firearms, poisoning) could also help inform clinical
care and data are accumulating supporting the value of such
interventions.
Strengths and Limitations
The current review supplements the literature by conducting
a systematic review on not only suicide attempts and self-
harm, but also addresses the links between suicidal ideation
and depressive symptoms in adolescents. While we were able to
add a more comprehensive component to the systematic review,
due to the complexity of the varied studies and primary and
secondary outcomes, additional research is needed to identify
effective treatment strategies, provide guidance regarding how
to best personalize treatment and match youths and families
to treatments that are most likely to be beneficial, and to
develop cost-effective treatment delivery strategies. There are
no published RCTs of pharmacological interventions for the
reduction of self-harm. However, many young people who self-
harm are offered pharmacological treatment to address co-
occurring psychiatric symptoms. While an investigation of the
possible influence of pharmacological interventions was out of
the scope of the current review, future work addressing both
psychosocial and psychopharmacological elements of treatment
is needed. To date, there have been no RCTs evaluating the
efficacy of psychopharmacological treatments for reducing self-
harm, though this may also be a potential avenue for future
research. In following the methodology of the previous analysis,
studies which did not adhere to an RCT design were excluded,
though may nonetheless be insightful in regards to reducing
self-harm in young people. Additionally, as the search terms
used to identify studies on self-harm were derived from the
subject headings of the relevant databases and were limited to
studies published in English, some studies representing unique
cultural outlooks on self-harm may have been omitted. Indeed,
the heterogeneity of the studies included in this review makes
it difficult to account for additional influential factors, including
the participants’ previous engagement with therapy, their mental
health histories and psychiatric co-morbidities, and the quantity
and severity of their previous self-harm, among others. Future
reviews may wish to pay particular attention to such elements
in order to understand whether certain interventions work
more effectively in some unique cases over others. A variety
of additional factors, including small and highly selective
samples limit the generalizability of the findings in some of
the studies included in this review. Finally, the current failure
to replicate certain interventions in different cultural contexts
underscores the challenges for exporting treatment strategies
across different cultures and settings, and the importance of
building international consensus and developing care strategies
that can work across diverse cultural contexts and health systems.
Future Directions for Effective
Interventions
Considering future directions for studies aimed at decreasing
self-harm and suicide attempts in adolescents, some treatments
(such as DBT-A) led to significant reductions on outcomes
more rapidly than others. Cost analyses could further inform
knowledge about the viability of delivering certain interventions
over others in routine clinical settings to large populations.
Several of the evaluated interventions require multiple personnel
Frontiers in Psychiatry | www.frontiersin.org 13 November 2018 | Volume 9 | Article 583
Iyengar et al. RCTs of Self-Harm Intervention
(e.g., 2-therapist model used in the Integrated CBT model,
the SAFETY intervention, and DBT-A with skills trainer
and individual therapist). Likewise, whereas several of the
interventions are completed in under 6 months, others require
long and perhaps costly commitments to therapy, which may act
as barriers to treatment adherence, particularly for adolescents
who experience a lack of motivation to attend sessions as a
symptom of depression (49, 50). These cost considerations will
also have a major bearing on the likelihood of interventions being
implemented in routine health setting. Additionally, some of the
multi-component treatments, such as DBT-A which requires 1 h
weekly psychotherapy plus 2 h of multi-family skills group may
require a more intensive and burdensome treatment dose than
needed for some youths and families. Stepped care approaches
that match treatment intensity to assessed level of risk and
need may prove helpful for identifying the most cost-effective
treatment delivery strategies.
The results of a large, multi-center RCT investigating the
effectiveness of Family Therapy in reducing self-harm in
adolescents (51) were published following the intial literature
review, and thus cannot be included in the results of the
current update. However, these results, which demonstrated that
Family Therapy was more costly and no more beneficial than
treatment as usual, are nonetheless an important contribution
to understanding which interventions are viable and effective
in reducing self-harm in young people. In comparison to other
therapies which include a strong family-based component as
part of the treatment (such as DBT-A, MBT-A, and RAP-P
among others), participants in the Family Therapy group were
provided with 6–8 monthly sessions of therapy; far fewer than
those participants which received any of the aforementioned
treatments, indicating that the duration and intensity of the
treatment may be an important factor in the success of an
intervention aiming to reduce self-harm and preventing suicide
attempts.
Other RCTs published following the completion of our search,
include a study further strengthening the efficacy of DBT-A in
reducing self-harm post-treatment, as well as a significantly lower
number of suicide attempts and significantly fewer episodes
of non-suicidal self-injurious behavior. Although no significant
between-group differences were found at longer-term (12-
month) follow-up in number of self-harm episodes, youths in
the DBT-A were significantly more likely to show clinically
significant change, defined as the absence of any self-harm,
through the 12-month follow-up (52). Another study showed
that young people with longer inpatient admissions were more
likely to have multiple self-harm episodes, than young people
treated with intensive community care (53).
Lastly, there were several unpublished protocol studies of
RCTs for this subject population (54–58) and studies in progress
(59–61), which we were unable to use for our systematic review. It
is our hope that when these protocols are applied and published,
such findings will greatly advance the field, and shed further light
on effective treatments for adolescents at-risk for suicide.
Our updated systematic review suggests that given the
heterogeneity of suicidal behavior, understanding which type of
intervention is most effective for adolescents at risk of suicide
can be a challenging but nonetheless paramount endeavor that
requires further attention.
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